Strategy

Antisense Pharma develops innovative drugs for targeted treatment of aggressive tumors, for which there is a very high unmet medical need. Such tumors include highly malignant gliomas (brain tumors), pancreatic cancer, and malignant melanoma (skin cancer). Antisense Pharma pursues an immunotherapeutic strategy with a potentially long-lasting effect against malignant tumor diseases. In the medium-term, Antisense Pharma is expanding its drug development to include additional tumor diseases as well as other, as yet incurable diseases. 

Antisense Pharma covers a wide spectrum of drug development – beginning with the discovery and patenting of a suitable drug candidate, to its preclinical and clinical development.